
Please try another search
On June 24, 2019, Pernix Sleep, Inc. went out of business as per its Chapter 11 liquidation filing under bankruptcy. Pernix Sleep, Inc., a specialty pharmaceutical company, engages in developing and commercializing prescription therapeutics to treat medical conditions. The company focuses on in-licensing, developing, and marketing proprietary products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Its products include Silenor, a nonscheduled prescription medication for the treatment of sleep maintenance insomnia, which include adults and the elderly who have sleep maintenance insomniaA type of insomnia, people with chronic sleep maintenance insomnia (insomnia lasting more than three weeks), and people with transient insomnia. The company markets its products in the United States. Pernix Sleep, Inc. was formerly known as Somaxon Pharmaceuticals, Inc. The company was founded in 2003 and is headquartered in San Diego, California.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review